Announcement of TTY Biopharm's unaudited income information in November 2021
2021.12.13
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/12/10 | Time of announcement | 15:34:48 |
| Subject | Announcement of TTY Biopharm's unaudited income information in November 2021 | ||||
| Date of events | 2021/12/10 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/12/10 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $430,974 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $100,002 thousands, and a consolidated income before tax of $111,362 thousands in November 2021; net income attributed to stockholders of the parent company was $87,375 thousands; EPS is $0.35. Year-to-date consolidated net sales was $4,062,985 thousands (in NT dollars; unaudited), a consolidated operating profit was $819,538 thousands and consolidated income before tax was $957,181 thousands until November 2021; year-to-date net income attributed to stockholders of the company was $716,854 thousands; EPS is $2.88. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||